CAMP Q4 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94M+12.4% YoY

Gross Profit

$38M40.8% margin

Operating Income

$4M4.5% margin

Net Income

$12M12.6% margin

EPS (Diluted)

$0.33

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$475M

Total Liabilities

$274M

Stockholders' Equity

$201M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$83M	+12.4%
Gross Profit	$38M	$35M	+8.7%
Operating Income	$4M	$2M	+134.6%
Net Income	$12M	-$2M	+873.1%

Revenue Segments

Telematics Systems

$78M83%

Software & Subscription Services

$16M17%

Geographic Segments

United States

$67M72%

Europe, Middle East and Africa

$11M12%

Canada

$4M5%

All other

$4M4%

Asia and Pacific Rim

$3M4%

South America

$3M3%